Biological kits/fujirebio/mitsuya, hiroaki

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600334P
Awardee
Awarding agency
Obligated
$14,260

Award facts

Contract value 100% obligated
$14,260.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Malvern, PA 19355, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Vendor DUNS or Name Change - Non-Novation 1 $0
Original award $14,260

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Fujirebio US, Inc. for biological kits valued at $14,260.04, with an award date of May 11, 2016 and completion date of June 10, 2016. Performance occurs in Malvern, Pennsylvania. The order is a firm fixed price commercial purchase for diagnostic or research-grade biological materials, reflecting the vendor's core capability in medical diagnostics manufacturing and assay kit supply to federal health agencies.

Quick answers

Who was awarded contract HHSN261201600334P?

HHSN261201600334P was awarded to Fujirebio US, Inc. by National Cancer Institute (National Institutes of Health) on May 11, 2016.

How much is contract HHSN261201600334P worth?

The government has obligated $14,260 on HHSN261201600334P.

Was contract HHSN261201600334P competed?

The extent of competition for HHSN261201600334P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login